SCHEMBL10176528

SCHEMBL10176528

CCOC(=O)COc1ccc(/N=C2/NC(=O)/C(=C/c3cnc(NC(=O)C4CC4)s3)S2)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.42
NPSR1 Q6W5P4 4/20 0.42
RECQL P46063 1/20 0.42
PTPN7 P35236 3/20 0.42
PTPN12 Q05209 3/20 0.42
PTPN22 Q9Y2R2 3/20 0.42
DUSP3 P51452 2/20 0.42
LMNA P02545 1/20 0.41
HDAC4 P56524 4/20 0.39
HDAC8 Q9BY41 3/20 0.39
ABL1 P00519 1/20 0.39
POLB P06746 2/20 0.39
PTPN5 P54829 1/20 0.39
PTPN11 Q06124 1/20 0.39
HPGD P15428 3/20 0.38
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
RNASEL Q05823 1/20 0.36
PTP4A3 O75365 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10176532 0.92 PTPN7 (0.44) MAPTNPSR1RECQLPTPN7PTPN12
SCHEMBL10176547 0.89 MAPT (0.47) MAPTNPSR1RECQLLMNAABL1
SCHEMBL10176524 0.88 MAPT (0.40) MAPTNPSR1RECQLLMNAABL1
SCHEMBL653370 0.87 MAPT (0.40) MAPTNPSR1RECQLPTPN7PTPN12
SCHEMBL650770 0.87 MAPT (0.41) MAPTNPSR1RECQLPTPN7PTPN12
SCHEMBL699657 0.87 MAPT (0.41) MAPTNPSR1RECQLPTPN7PTPN12
SCHEMBL652415 0.87 MAPT (0.41) MAPTNPSR1RECQLPTPN7PTPN12
SCHEMBL653897 0.86 MAPT (0.40) MAPTNPSR1RECQLPTPN7PTPN12
SCHEMBL653891 0.86 MAPT (0.41) MAPTNPSR1RECQLLMNAABL1
SCHEMBL653892 0.86 MAPT (0.41) MAPTNPSR1RECQLLMNAABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 MAPT 3657/4885NPSR1 4464/4885RECQL 1217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.